The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a hernia.
It was reported that after implant, the patient experienced recurrent hernia due to failure of the mesh, small bowel obstruction, dense visceral adhesions of the small bowel to the mesh infection and partial removal of the mesh.
Treatment provided for these conditions include removal.
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral incisional hernia.
It was reported that after implant, the patient experienced recurrent hernia due to failure of the mesh, small bowel obstruction, necrosis, dense visceral adhesions of the small bowel to the mesh, hematoma, open wound, bleeding, and infection.
Treatment provided for these conditions include removal, exploratory laparotomy, repair of hernia, repair of enterotomies small bowel, evacuation of hematoma, wound washout and debridement, wound vac, and partial removal of the mesh.
|